Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma PLC

5 Dec 2005 15:08

HBM BioVentures (Cayman) Ltd05 December 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) HBM BIOVENTURES (CAYMAN) LTD Company dealt in SKYEPHARMA PLC Class of relevant securityto which the dealings being disclosed relate (Note 2) ORDINARY SHARES Date of dealing 2 DECEMBER 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 63,780,450 (8.46%)(2) Derivatives (other than options) NA (3) Options and agreements to purchase/sell NA Total 63,780,450 (8.46%) (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5)PURCHASE (02.12.2005) 3,003,923 0.523042SALE N/A N/A (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 05 DECEMBER 2005 Contact name JOHN ARNOLD Telephone number +1 345 946 8002 If a connected EFM, name of offeree/offeror with which connected NA If a connected EFM, state nature of connection (Note 10) NA Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jul 20074:28 pmRNSDirector/PDMR Shareholding
11th Jul 20073:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20073:02 pmRNSRe: Share Purchase Plan
29th Jun 20071:27 pmRNSResult of AGM
29th Jun 20077:03 amRNSAGM Statement
27th Jun 200711:28 amRNSAppointment
26th Jun 20077:02 amRNSRe Agreement
21st Jun 200712:19 pmRNSHealthcare Conference
14th Jun 20079:30 amRNSHealth Care Conference
6th Jun 200711:28 amRNSHolding(s) in Company
31st May 20072:57 pmRNSShare Purchase Plan
31st May 200712:30 pmRNSRegulatory Approval
30th May 200710:51 amRNSHolding(s) in Company
15th May 20073:00 pmRNSAnnual Information Update
14th May 20071:30 pmRNSResearch Update
4th May 20074:47 pmRNSDirector Shareholding
4th May 20073:38 pmRNSEGM Result
4th May 20077:00 amRNSDelist from NASDAQ
3rd May 20071:18 pmRNSDirector/PDMR Shareholding
1st May 20075:10 pmRNSFurther re Final Results
1st May 20072:04 pmRNSRe: UBS Conference
26th Apr 20077:02 amRNSFinal Results
23rd Apr 20078:00 amRNSRegulatory Approval
18th Apr 200712:15 pmRNSCirc re. Incentive Plan
18th Apr 20077:01 amRNSEGM Circular
17th Apr 20074:57 pmRNSHolding(s) in Company
3rd Apr 20074:25 pmRNSDirector Shareholding
3rd Apr 20071:32 pmRNSInterest in Shares
3rd Apr 200710:16 amRNSAnnual Information Update
2nd Apr 20075:03 pmRNSInterest in Shares
2nd Apr 20073:39 pmRNSInterest in Shares
2nd Apr 20073:38 pmRNSRule 8.3- Skyepharma PLC-Amd
30th Mar 20075:20 pmRNSRule 8.3- Skyepharma PLC
26th Mar 200712:56 pmRNSTotal Voting Rights
26th Mar 20077:03 amRNSCompletion of Disposal
15th Mar 20077:01 amRNSAgreement for Zileuton CR
13th Mar 20073:55 pmRNSHolding(s) in Company
12th Mar 20074:53 pmRNSHolding(s) in Company
9th Mar 20079:21 amRNSPresentation at Conference
1st Mar 20074:41 pmRNSShare Purchase Plan
20th Feb 20077:03 amRNSNotification of Shares
14th Feb 20072:37 pmRNSPresentation at Conference
8th Feb 200710:48 amRNSEGM Statement
1st Feb 20073:21 pmRNSShare Purchase Plan
29th Jan 200712:48 pmRNSNotification of Interests
22nd Jan 20079:00 amRNSNotification of Shares
16th Jan 20077:01 amRNSCircular Posting
9th Jan 20078:49 amRNSUK Release Important Details
9th Jan 20077:01 amRNSInjectable Sale & Placing
9th Jan 20077:01 amRNSInjectable Sale & Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.